Related Experiment Video
Updated: Dec 11, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Impact of Hematologic Malignancies on Outcome of Cardiac Surgery
Anita Nguyen1, Hartzell V Schaff1, Arman Arghami1
1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
Insights
Patients with hematologic malignancy undergoing cardiac surgery face similar early outcomes but reduced long-term survival compared to controls. Cardiac procedures should not be withheld from these patients if they stand to benefit.
Area of Science:
- Cardiology
- Hematology
- Oncology
Background:
- Previous studies indicate increased risks for patients with hematologic malignancy undergoing cardiac surgery.
- This review compares clinical outcomes in cardiac surgery patients with and without a history of blood dyscrasia.
Purpose of the Study:
- To compare clinical outcomes between cardiac surgery patients with a history of hematologic malignancy and matched controls without known blood dyscrasia.
Main Methods:
- A retrospective review of 37,839 elective cardiac surgeries performed between January 1993 and June 2017.
- 612 patients with hematologic malignancy were matched to 612 controls based on various factors.
- Comparison of operative details, early postoperative complications, and late survival.
Main Results:
- Patients with hematologic malignancy had lower hemoglobin but similar platelet counts.
- Increased need for postoperative blood transfusions was observed in the malignancy group (47.4% vs 35.6%).
- Reoperations for bleeding, stroke incidence, and 30-day mortality were similar; however, overall survival was reduced in patients with hematologic malignancy.
Conclusions:
- Early postoperative outcomes for cardiac surgery patients with hematologic malignancy are comparable to matched controls.
- Despite reduced late survival, cardiac surgery should be considered for patients with hematologic malignancy who would benefit from the procedure.
Background:
Previous studies suggest that patients with prior or current hematologic malignancy are at increased risk of intraoperative and postoperative complications when undergoing cardiac surgery. The aim of this review was to compare clinical outcomes of patients with a history of hematologic malignancy to those of similar patients with no known blood dyscrasia.
Methods:
From January 1993 to June 2017, 37,839 patients underwent elective cardiac surgery at Mayo Clinic. We matched 612 patients (1.6%) with a history of hematologic malignancy to 612 controls, and compared operative details, early postoperative complications, and late survival.
Results:
The median age of matched patients with hematologic malignancy was 71 years (interquartile range [IQR], 62 to 77) and 71 years (IQR, 62 to 77) for patients without cancer. Patients with prior diagnosis of malignancy had lower hemoglobin levels, 12.8 (IQR, 11.5 to 13.8) vs 13.5 (IQR, 12.2 to 14.6; P < .001), but similar platelet counts, 195 (IQR, 147 to 263) vs 203 (IQR, 170 to 245; P = .533). Patients with malignancy were at greater risk of receiving postoperative blood transfusions (47.4% vs 35.6%, P < .001). However, reoperations for postoperative bleeding (4.7% vs 3.3%, P = .253) and stroke (1.3% vs 1.3%, P > .999) were similar. Thirty-day mortality was 3.3% among patients with hematologic malignancy and 1.5% among matched controls (P = .061). Overall survival among patients with cancer was reduced (P < .0001).
Conclusions:
Although late survival is reduced in patients with hematologic malignancies, early outcomes are generally similar to those of matched controls. Therefore, surgery should not be withheld from patients with a diagnosis of hematologic malignancy who would benefit from cardiac procedures.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pericarditis IV: Nursing Management

